Modelling amyotrophic lateral sclerosis: progress and possibilities - PubMed
pubmed.ncbi.nlm.nih.gov
Modelling amyotrophic lateral sclerosis: progress and possibilities - PubMed
Overview of the ALS drug pipeline from a nice recent review. Authors note "approaches that are under-represented, based on current knowledge of the pathophysiology of ALS, include those targeting mitochondrial dysfunction and proteostasis"
source: https://t.co/Szidtj6Luv https://t.co/e85fU5GzWz
I’m now sharing (in a follow-up post) links to the tests I conducted comparing Manus AI @ManusAI_HQ to OpenAI’s Deep Research. The prompt was highly complex: evaluating ME/CFS disease, generating new hypotheses, and identifying novel therapeutics, using our recent multi-omics AI paper preprint as the initial context (link also... See more
Derya Unutmaz, MDx.com
Short of building an AGI God this is where your ML skills might make the biggest difference. Green's lucid understanding of biomedical research both lets him see through academic twaddle and say the concrete «how» of using Scale to solve health end-to-end.
https://t.co/xuhlEZhm6q https://t.co/OO49Q1E5R6